SCHEMBL30173261

SCHEMBL30173261

Oc1ccc2ccccc2c1C=CCCCC=Cc1c(O)ccc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.58
MAPT P10636 10/20 0.51
KDM4E B2RXH2 7/20 0.51
L3MBTL1 Q9Y468 5/20 0.51
ALDH1A1 P00352 5/20 0.51
THRB P10828 3/20 0.51
HSD17B10 Q99714 2/20 0.51
MPI P34949 2/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
KMT2A Q03164 6/20 0.50
CYP1A2 P05177 2/20 0.50
HIF1A Q16665 2/20 0.50
RIOK2 Q9BVS4 1/20 0.50
CYP2D6 P10635 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 5/20 0.49
GAA P10253 4/20 0.49
HPGD P15428 2/20 0.49
ATM Q13315 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7915280 0.85 ERN1 (0.70) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL7915285 0.85 ERN1 (0.70) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL8233219 0.81 MAPT (0.57) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL9446432 0.80 ERN1 (0.44) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL31355738 0.80 CYP1A2 (0.48) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL28503936 0.76 RRM1 (0.63) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL2558919 0.75 ERN1 (0.68) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL2558917 0.75 ERN1 (0.68) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL11508389 0.74 ERN1 (0.56) ERN1MAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL1450843 0.74 ERN1 (0.61) ERN1MAPTKDM4EL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4366701-A1 NANOPARTICLES FOR CANCER TREATMENT Immix Biopharma, Inc. (US) 2024-05-15 EP disclosed
WO-2023283380-A1 NANOPARTICLES FOR CANCER TREATMENT IMMIX BIOPHARMA, INC. (US) 2023-01-12 WO disclosed